Rothschild & Co Asset Management US’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,351
Closed -$5.23M 272
2021
Q4
$5.23M Sell
20,351
-1,156
-5% -$283K 0.06% 215
2021
Q3
$5.22M Sell
21,507
-249
-1% -$60.9K 0.06% 217
2021
Q2
$4.5M Sell
21,756
-1,756
-7% -$358K 0.05% 226
2021
Q1
$4.43M Buy
+23,512
New +$4.15M 0.05% 227
2017
Q3
Sell
-5,137
Closed -$448K 441
2017
Q2
$448K Buy
+5,137
New +$435K 0.01% 549
2016
Q3
Sell
-5,209
Closed -$401K 551
2016
Q2
$401K Buy
5,209
+777
+18% +$61.3K 0.01% 488
2016
Q1
$346K Buy
4,432
+359
+9% +$25.1K 0.01% 418
2015
Q4
$275K Buy
+4,073
New +$284K 0.01% 399

Other funds holding HCA

Rothschild & Co Asset Management US's HCA Position: Q1 2022 in Review

Rothschild & Co Asset Management US sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 20,351 shares — an estimated $5.23M sold.

Rothschild & Co Asset Management US first reported a position in HCA in Q4 2015 and held it in 8 quarters. The position peaked at $5.23M in Q4 2021. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

  • Rothschild & Co Asset Management US reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 20,351 HCA Healthcare shares in Q1 2022, an estimated $5.23M.
  • Rothschild & Co Asset Management US first reported a position in HCA Healthcare in Q4 2015 and held it in 8 quarters.
  • Rothschild & Co Asset Management US's HCA Healthcare position peaked at $5.23M in Q4 2021.
  • 968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2022, filed 13 May 2022.